Non Alcoholic Fatty Liver Disease (NAFLD) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 205 pages | ID: N333E66F298EN
VPAResearch

Abstracts

Non Alcoholic Fatty Liver Disease (NAFLD) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Non Alcoholic Fatty Liver Disease (NAFLD) disease clinical trials. The research work analyzes the ongoing Non Alcoholic Fatty Liver Disease (NAFLD) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Non Alcoholic Fatty Liver Disease (NAFLD) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Non Alcoholic Fatty Liver Disease (NAFLD) clinical trials.

Scope of the Report-

• Ongoing Non Alcoholic Fatty Liver Disease (NAFLD) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Non Alcoholic Fatty Liver Disease (NAFLD) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Non Alcoholic Fatty Liver Disease (NAFLD) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Non Alcoholic Fatty Liver Disease (NAFLD) Trials by Phase
3.2 Ongoing Non Alcoholic Fatty Liver Disease (NAFLD) Trials by Type
3.3 Ongoing Non Alcoholic Fatty Liver Disease (NAFLD) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Non Alcoholic Fatty Liver Disease (NAFLD) Trials
4.2 Top 10 Countries conducting Non Alcoholic Fatty Liver Disease (NAFLD) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Non Alcoholic Fatty Liver Disease (NAFLD) Trials by Sponsor Type
5.2 Non Alcoholic Fatty Liver Disease (NAFLD) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Non Alcoholic Fatty Liver Disease (NAFLD) Trials by year
6.2 Subjects Recruited for Non Alcoholic Fatty Liver Disease (NAFLD) Trials by Phase
6.3 Subjects Recruited for Non Alcoholic Fatty Liver Disease (NAFLD) Trials by Trial Type
6.4 Subjects Recruited for Non Alcoholic Fatty Liver Disease (NAFLD) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Non Alcoholic Fatty Liver Disease (NAFLD) Trials- Phase
7.2 Ongoing Non Alcoholic Fatty Liver Disease (NAFLD) Trials- Phase
7.3 Ongoing Non Alcoholic Fatty Liver Disease (NAFLD) Trials- Phase
7.4 Ongoing Non Alcoholic Fatty Liver Disease (NAFLD) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials by Country
Figure 2: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials by Phase of Development, 2018
Figure 3: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials by Status, 2018
Figure 4: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials by Type, 2018
Figure 5: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials Split by Region, 2000-2018
Figure 6: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials by Type of Economy, 2018
Figure 7: Non Alcoholic Fatty Liver Disease (NAFLD)- Enrolment by Phase, 2018
Figure 8: Non Alcoholic Fatty Liver Disease (NAFLD)- Enrolment by Trial Type, 2018
Figure 9: Non Alcoholic Fatty Liver Disease (NAFLD)- Enrolment by Recruitment Status, 2018
Figure 10: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials by Sponsor Type, 2018
Figure 11: Non Alcoholic Fatty Liver Disease (NAFLD)- Enrolment by Type of Sponsors
Figure 12: Non Alcoholic Fatty Liver Disease (NAFLD)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials by Sponsor Type, 2018
Table 2: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials by Economy Type, 2018
Table 3: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials by Region, 2018
Table 4: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Non Alcoholic Fatty Liver Disease (NAFLD)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Non Alcoholic Fatty Liver Disease (NAFLD)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Non Alcoholic Fatty Liver Disease (NAFLD)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Non Alcoholic Fatty Liver Disease (NAFLD)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Non Alcoholic Fatty Liver Disease (NAFLD)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company